581 related articles for article (PubMed ID: 24685455)
1. Molecular modeling of Gram-positive bacteria peptidoglycan layer, selected glycopeptide antibiotics and vancomycin derivatives modified with sugar moieties.
Ślusarz R; Szulc M; Madaj J
Carbohydr Res; 2014 May; 389():154-64. PubMed ID: 24685455
[TBL] [Abstract][Full Text] [Related]
2. Oritavancin: mechanism of action.
Zhanel GG; Schweizer F; Karlowsky JA
Clin Infect Dis; 2012 Apr; 54 Suppl 3():S214-9. PubMed ID: 22431851
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of oritavancin and related glycopeptide antibiotics.
Allen NE; Nicas TI
FEMS Microbiol Rev; 2003 Jan; 26(5):511-32. PubMed ID: 12586393
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics.
Leimkuhler C; Chen L; Barrett D; Panzone G; Sun B; Falcone B; Oberthür M; Donadio S; Walker S; Kahne D
J Am Chem Soc; 2005 Mar; 127(10):3250-1. PubMed ID: 15755121
[TBL] [Abstract][Full Text] [Related]
5. Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin.
Münch D; Engels I; Müller A; Reder-Christ K; Falkenstein-Paul H; Bierbaum G; Grein F; Bendas G; Sahl HG; Schneider T
Antimicrob Agents Chemother; 2015 Feb; 59(2):772-81. PubMed ID: 25403671
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Staphylococcus aureus Cell Wall Biosynthesis by Desleucyl-Oritavancin: a Quantitative Peptidoglycan Composition Analysis by Mass Spectrometry.
Chang JD; Foster EE; Thadani AN; Ramirez AJ; Kim SJ
J Bacteriol; 2017 Aug; 199(15):. PubMed ID: 28507244
[TBL] [Abstract][Full Text] [Related]
7. Conformational and quantitative characterization of oritavancin-peptidoglycan complexes in whole cells of Staphylococcus aureus by in vivo 13C and 15N labeling.
Cegelski L; Steuber D; Mehta AK; Kulp DW; Axelsen PH; Schaefer J
J Mol Biol; 2006 Apr; 357(4):1253-62. PubMed ID: 16483598
[TBL] [Abstract][Full Text] [Related]
8. Structures of Staphylococcus aureus cell-wall complexes with vancomycin, eremomycin, and chloroeremomycin derivatives by 13C{19F} and 15N{19F} rotational-echo double resonance.
Kim SJ; Cegelski L; Preobrazhenskaya M; Schaefer J
Biochemistry; 2006 Apr; 45(16):5235-50. PubMed ID: 16618112
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulations of the secondary-binding site in disaccharide-modified glycopeptide antibiotics.
Olademehin OP; Shuford KL; Kim SJ
Sci Rep; 2022 Apr; 12(1):7087. PubMed ID: 35490171
[TBL] [Abstract][Full Text] [Related]
10. Hidden Mode of Action of Glycopeptide Antibiotics: Inhibition of Wall Teichoic Acid Biosynthesis.
Singh M; Chang J; Coffman L; Kim SJ
J Phys Chem B; 2017 Apr; 121(16):3925-3932. PubMed ID: 28368603
[TBL] [Abstract][Full Text] [Related]
11. Selective cleavage of D-Ala-D-Lac by small molecules: re-sensitizing resistant bacteria to vancomycin.
Chiosis G; Boneca IG
Science; 2001 Aug; 293(5534):1484-7. PubMed ID: 11520986
[TBL] [Abstract][Full Text] [Related]
12. Molecular interactions between glycopeptide vancomycin and bacterial cell wall peptide analogues.
Xing B; Jiang T; Wu X; Liew R; Zhou J; Zhang D; Yeow EK
Chemistry; 2011 Dec; 17(50):14170-7. PubMed ID: 22083883
[TBL] [Abstract][Full Text] [Related]
13. New insights into glycopeptide antibiotic binding to cell wall precursors using SPR and NMR spectroscopy.
Treviño J; Bayón C; Ardá A; Marinelli F; Gandolfi R; Molinari F; Jimenez-Barbero J; Hernáiz MJ
Chemistry; 2014 Jun; 20(24):7363-72. PubMed ID: 24805824
[TBL] [Abstract][Full Text] [Related]
14. A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.
Guskey MT; Tsuji BT
Pharmacotherapy; 2010 Jan; 30(1):80-94. PubMed ID: 20030476
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles.
Printsevskaya SS; Reznikova MI; Korolev AM; Lapa GB; Olsufyeva EN; Preobrazhenskaya MN; Plattner JJ; Zhang YK
Future Med Chem; 2013 Apr; 5(6):641-52. PubMed ID: 23617428
[TBL] [Abstract][Full Text] [Related]
16. Quantum simulations of the structure and binding of glycopeptide antibiotic aglycons to cell wall analogues.
Lee JG; Sagui C; Roland C
J Phys Chem B; 2005 Nov; 109(43):20588-96. PubMed ID: 16853665
[TBL] [Abstract][Full Text] [Related]
17. The Carboxyl Terminus of Eremomycin Facilitates Binding to the Non-d-Ala-d-Ala Segment of the Peptidoglycan Pentapeptide Stem.
Chang J; Zhou H; Preobrazhenskaya M; Tao P; Kim SJ
Biochemistry; 2016 Jun; 55(24):3383-91. PubMed ID: 27243469
[TBL] [Abstract][Full Text] [Related]
18. Glycopeptide antibiotics and their novel semi-synthetic derivatives.
Jeya M; Moon HJ; Lee KM; Kim IW; Lee JK
Curr Pharm Biotechnol; 2011 Aug; 12(8):1194-204. PubMed ID: 21470154
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.
Ge M; Chen Z; Onishi HR; Kohler J; Silver LL; Kerns R; Fukuzawa S; Thompson C; Kahne D
Science; 1999 Apr; 284(5413):507-11. PubMed ID: 10205063
[TBL] [Abstract][Full Text] [Related]
20. Direct fluorescence polarization assay for the detection of glycopeptide antibiotics.
Yu L; Zhong M; Wei Y
Anal Chem; 2010 Aug; 82(16):7044-8. PubMed ID: 20704393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
